Inhibikase Therapeutics, Inc. · NASDAQ:IKT

Berman Dennis N exercised options for 21,854 Inhibikase Therapeutics, Inc. shares (Form 4)

Traded Jul 30, 2026 · Filed Jul 31, 2026

On Jul 30, 2026, Berman Dennis N (Director) exercised options for 21,854 Inhibikase Therapeutics, Inc. shares at US$1.26 for US$27,536, leaving 21,854 shares. Filed Jul 31, 2026 (Form 4).

Options exercised
21,854 shares
Price
US$1.26
Value
US$27,536
Holding after
21,854 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 30, 2026Common StockOption exercise21,854US$1.2621,854Direct

Source

View original at SEC

Related